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Abstract
Preconditioning nerve injuries activate a pro-regenerative program that enhances axon regeneration for most
classes of sensory neurons. However, nociceptive sensory neurons and central nervous system neurons
regenerate poorly. In hopes of identifying novel mechanisms that promote regeneration, we screened for drugs
that mimicked the preconditioning response and identified a nociceptive ligand that activates a preconditioning-
like response to promote axon outgrowth. We show that activating the ion channel TRPV1 with capsaicin induces
axon outgrowth of cultured dorsal root ganglion (DRG) sensory neurons, and that this effect is blocked in TRPV1
knockout neurons. Regeneration occurs only in NF200-negative nociceptive neurons, consistent with a cell-
autonomous mechanism. Moreover, we identify a signaling pathway in which TRPV1 activation leads to calcium
influx and protein kinase A (PKA) activation to induce a preconditioning-like response. Finally, capsaicin
administration to the mouse sciatic nerve activates a similar preconditioning-like response and induces enhanced
axonal outgrowth, indicating that this pathway can be induced in vivo. These findings highlight the use of local
ligands to induce regeneration and suggest that it may be possible to target selective neuronal populations for
repair, including cell types that often fail to regenerate.
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Introduction
Axon regeneration is required to restore function after
nervous system damage. CNS neurons are notoriously
regeneration-resistant, and even some subtypes of pe-
ripheral nervous system (PNS) neurons have a decreased
capacity to regenerate. Identifying strategies to improve
regeneration of otherwise regeneration-resistant neurons
could be beneficial after CNS or PNS damage.
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Significance Statement
After injury or neurodegenerative disease, axons need to regenerate to restore function. Unfortunately, no
current therapies achieve this goal. We performed a drug screen in adult sensory neurons to identify agents
that effectively reprogram neurons into a progrowth state. We demonstrate that capsaicin, a TRPV1 agonist,
activates a pro-axon growth program. This mechanism requires calcium influx and PKA activity and leads
to the activation of the pro-regenerative transcription factor CREB. Hence, activation of ion channels can
promote axon regeneration, an exciting finding, since many ion channels are druggable targets. Moreover,
these findings suggest an approach for enhancing axon regeneration in selective populations of neurons.
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After injury, local signaling and cytoskeletal rearrange-
ment establishes new growth cones (Bradke et al., 2012).
This step is necessary but not sufficient for long-distance
regeneration. Most dorsal root ganglion (DRG) neurons
initiate a robust pro-regenerative transcriptional program
that reprograms neurons into a regenerative state (Tede-
schi, 2011). Prior activation of this program by a condi-
tioning lesion removes that delay and accelerates
regeneration following a second test lesion (McQuarrie
and Grafstein, 1973; McQuarrie et al., 1977; Smith and
Skene, 1997). This preconditioning effect results from
activation of the pro-regenerative program by the condi-
tioning injury so that, at the time of the second injury,
neurons are already in a pro-regenerative state. Mimick-
ing the preconditioning response is an exciting therapeu-
tic strategy to enhance regeneration, particularly in
regeneration-resistant neurons. The cAMP stimulator for-
skolin was the first discovered agent with this capacity
(Kilmer and Carlsen, 1984). Further studies determined
that elevating cAMP/PKA signaling not only stimulated
regeneration of sensory neurons on growth-permissive
substrates, but also stimulated regeneration over inhibi-
tory substrates as well as into the CNS in vivo (Cai et al.,
1999; Qiu et al., 2002; Gao et al., 2004). Mechanistically,
PKA phosphorylates CREB to induce a pro-regenerative
transcriptional program (Cai et al., 2002; Gao et al., 2004).
Drugs that manipulate these existing pro-regenerative
pathways offer an exciting strategy for nervous system
repair.
We set out to perform a screen to identify drugs that
mimic preconditioning in cultured adult sensory neurons.
Importantly, we sought drugs that work in the absence of
injury. Traditionally, regeneration screens apply drugs af-
ter injury and assess growth over inhibitory substrates.
This strategy has successfully identified signaling cas-
cades such as the PKC and AKT pathways, as well as
drugs that alter microtubule density and dynamics (Gao
et al., 2010; Samara et al., 2010; Usher et al., 2010).
However, these screens were not ideal for finding drugs
that mimic the preconditioning phenomenon in the ab-
sence of injury. First, the drugs were present as the axons
were growing, so it was difficult to know whether these
drugs (a) act locally at the growth cone to promote out-
growth or (b) mimic preconditioning to activate the pro-
regenerative program. Second, because dissection of
DRG neurons from the animal is an injury, the drugs were
competing with the endogenous injury-signaling program.
Hence, the drugs would need to enhance regeneration
beyond the natural injury stimuli to be identified. As an
alternative approach, we sought to design a screen in
which drugs would be applied in the absence of injury
signaling and before the period of axonal outgrowth. To
achieve this, we used our previously described assay in
which compounds can be applied to neurons in the ab-
sence of injury and washed out, and neurons can be
replated to initiate new neurite outgrowth (Frey et al.,
2015). This allows us to distinguish between the activation
phase and growth phase of axonal outgrowth and so
identify drugs that mimic preconditioning and “repro-
gram” uninjured DRG neurons into a regenerative state.
After screening 480 test compounds, we discovered
that TRPV1 agonists mimicked preconditioning. Capsai-
cin upregulated the pro-growth transcription factor phos-
phorylated CREB and induced PKA-dependent axon
outgrowth. Local application of capsaicin to the sciatic
nerve also induced axon outgrowth, indicating that TRPV1
activation within the axon can induce this signaling path-
way. This demonstrates that ion channel ligands can tar-
get selective populations of neurons for regeneration.
Furthermore, these results illustrate the utility of this assay




Adult CD1 mice were purchased from Charles River.
TRPV1 knockout (KO) mice (Caterina et al., 2000) were
provided by Dr. Robert Gereau of Washington University
in St. Louis. Both male and female mice were used.
Mouse husbandry was performed under the supervision
of the Division of Comparative Medicine at Washington
University.
Primary DRG neuron culture
DRG neurons were cultured as described (Frey et al.,
2015). Briefly, all DRG were dissected from adult mice and
incubated in 0.35 mg/ml Liberase Blendzyme (Roche), 10
mg/ml bovine serum albumin (Sigma), and 0.6 mg/ml
DNase (Sigma) for 15 min, followed by 0.05% trypsin-
EDTA (Invitrogen) for 15 min at 37°C. Neurons were dis-
sociated in DMEM (Invitrogen) media containing 10% FBS
(Invitrogen), 100 U/ml penicillin, and 100 g/ml strepto-
mycin (Invitrogen) and plated on culture dishes or glass
chamber slides coated with 10 mg/ml of each PDL and
laminin (Sigma). Neurons were maintained at 37°C with
5% CO2. Media was changed on day in vitro 1 (DIV1), and
4 and 10 M AraC (Sigma) was added.
Drug treatment for axon regeneration screen
ICCB Known Bioactives Library (Maxene Iligan) was
provided from the high-throughput screening core at
Washington University in St. Louis. This library contains
480 drugs dissolved in DMSO. Drugs were diluted in
media and applied at 1:5000 and 1:1000 dilutions. This
gave final concentrations for most drugs between 1 and
30 M. DMSO and 1 M Nocodazole (Sigma) were used as
negative and positive controls, respectively (Valakh et al.,
2015). Ten negative and positive controls were included
on each 96-well plate. Nocodazole-treated wells were
normalized to DMSO-treated wells from the same plate to
control for plate-to-plate variability. If nocodazole failed to
induce robust neurite outgrowth, all data from that plate
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were excluded, and those compounds were tested on
new plates from a fresh culture. Over the entire screen,
DMSO-treated neurons had amean neurite length of 281 29
m/neuron compared to nocodazole-treated neurons, which
extended neurites to 1000  85 m/neuron.
Capsaicin treatment
Drugs were applied as described in the figures. Capsa-
icin (10 M, ApexBio or Cayman Chemical) was applied
for 10 min or 24 h. Inhibitors (capsazepine, Cayman
Chemical; EGTA, Sigma; H89, Sigma) were pretreated for
10–30 min before capsaicin treatment. All inhibitors
were present during capsaicin treatment. H89 was also
present during the rest of the 24-h activation phase. All
drugs were removed immediately before replating. For
phospho-CREB immunostaining, capsaicin was removed
20 min before fixation. For in vivo experiments, surgifoam
was dissolved in 200 M capsaicin or DMSO and applied
to the sciatic nerve.
Sciatic nerve surgeries
Mice were anesthetized with isofluorane. The surgical
site was shaved and cleaned with betadine solution. A
small incision was made along one thigh, and the sciatic
nerve was exposed. Surgifoam was applied or the nerve
was crushed. For nerve crush, number 5 forceps were
used to crush the nerve for 40 s (two 20-s orthogonal
crushes). After 2 d, all mice were sacrificed, and L4–6
DRG were collected for culture.
Replating assay
After drug treatment, neurons were washed with
DMEM, then treated with 0.025% Trypsin-EDTA for 5 min
at 37°C. Neurons were then dissociated and pipetted up
and down to strip off axons before being replated onto
PDL/laminin-coated 96-well plates (for screen) or glass
chamber slides (for manual assay) in culture media.
Immunocytochemistry and dye staining
After treatment, cells were fixed with 4% paraformalde-
hyde (Electron Microscopy Services) in PBS containing
0.1% Triton (PBST) for 20 min at room temperature. Neu-
rons were blocked in PBST containing 10% normal goat
serum. Primary antibody was incubated overnight at 4°C,
washed 3 times with PBST, incubated in secondary anti-
body for at least 1 h at room temperature, and washed
again with PBST before being coverslipped with Vecta-
shield (Vector Laboratories). Commercial antibodies used
were as follows: mouse anti-Tuj1 (Covance, 1:500; RRID:
AB_2313773), rabbit anti-pCREB (Cell Signaling Technolo-
gies, 1:500, RRID: AB_2561044), rabbit anti-NF200 (Sigma,
1:500, RRID: AB_477272), goat anti-mouse AF488 (Life
Technologies 1:1000, RRID: AB_138404), and goat anti-
rabbit Cy3 (Jackson Immuno, 1:1000, RRID: AB_10563288).
SCG10 antibody was purified from anti-SCG10 rabbit anti-
serum (Novus Biologicals) using the SulfoLink Kit (Thermo
Fisher). Ethidium homodimer (2 M, Sigma) and TMRM (50
nM, Sigma) were incubated for at least 15 min before imag-
ing.
Imaging and data analysis
For SCG10 and phospho-CREB, cells were imaged on
a Leica DMI 4000B Confocal microscope using 20 or
40 oil objectives. Images are maximum projections of
confocal stacks. Identical confocal settings were used for
samples within an experiment. Mean intensity of SCG10
in the soma or phospho-CREB in the nucleus was quan-
tified using ImageJ to determine the mean gray value and
normalized to the negative control (DMSO) within each
experiment. 50–100 neurons were imaged for each group
per experiment. For manual axon outgrowth, at least 100
neurons were imaged per group per experiment using a
Leica DFC7000T color fluorescence camera. Neurite
length was quantified by tracing the longest neurite from
each cell using the NeuronJ plugin for ImageJ (Meijering
et al., 2004; RRID: SCR_002074). For NF200 experiments,
NF200 immunostaining was imaged in addition to III-
tubulin. NF200 intensity and neurite length were analyzed
for at least 300 neurons per experiment and classified as
NF200 positive or negative. Cells with intermediate NF200
intensity were excluded from analysis. For the axon re-
generation screen, plates were imaged on the Operetta
High-Content Imaging System (PerkinElmer) at 20 mag-
nification.50 images were taken from each well. Images
were processed in Cell Profiler (Carpenter et al., 2006;
RRID: SCR_007358). We generated a pipeline to count
cells using Hoechst staining. Neurons were identified as
nuclei that were III-tubulin positive. This yielded total cell
and neuronal cell counts. The area of the somas was
subtracted from the III-tubulin channel so that only neu-
rites would be quantified. Cell Profiler then quantified the
total neurite length in each image. Mean neurite length
was calculated from the total neurite length from all neu-
rons in each well then divided by the total number of
neurons from the same well. This was then normalized to
the neurite outgrowth from negative controls. Cell counts
were used to rule out drugs that induced toxicity in the
screen. Ethidium homodimer and TMRM were also im-
aged on the Operetta High-Content Imaging System. At
least 100 neurons were imaged from each condition to
assess cell health. TMRM intensity was quantified simi-
larly to phospho-CREB and SCG10 immunostaining. For
viability, DRG neurons were identified and counted in
bright-field images. Cells that were positive for ethidium
homodimer were labeled “dead.” For in vivo axon regen-
eration, nerves were stained for III-tubulin and SCG10
and imaged on the Leica DMI 4000B Confocal using the
20 oil objective. The regeneration index was measured
as the distance where SCG10 intensity was 50% of the
level at the injury site, as we have previously described
(Shin et al., 2012a, 2014).
Experimental design and statistical analysis
Previous studies have indicated that a sample size of at
least 3 independent experiments is required to detect
significant changes between control (DMSO) and experi-
mental conditions, assuming   0.05. One independent
experiment is defined as a single DRG culture. All condi-
tions were tested in neurons from the same culture; there-
fore all experimental conditions were compared to their
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control counterparts. For in vivo experiments, 14 mice
were used. Half were treated with DMSO and half were
treated with capsaicin. All data are shown as mean 
SEM. Student’s t test, one-way ANOVA with Tukey post
hoc test, and two-way ANOVA with Bonferroni post hoc
test were used to determine if differences were statisti-
cally different. Student’s t test was performed on the
following data: Figs. 1G (paired), 2C (paired), 4B (paired),
8C (unpaired). One-way ANOVA with Tukey post hoc test
was performed on: Figs. 1E, 3B, 3E, 6C, 7C, 8C. Two-way
ANOVA with Bonferroni post hoc test was used with Figs.
1H, 2D, 3C, 3F, 4B, 4C, 5C, 6D, 7D, 8D, 9D . In figures, ,
, and  indicate p-values 0.05, 0.01, and 0.001,
respectively. Exact p-values are given in the text.
Results
An automated cellular imaging assay identifies pro-
regenerative drugs
We previously characterized an in vitro axon regenera-
tion assay capable of identifying drugs that mimic precon-
ditioning and activate the pro-regenerative program (Frey
et al., 2015). Adult DRG neurons are cultured for 4–6 d to
allow the axon regeneration program activated by the
initial dissection to turn off (Frey et al., 2015). Drugs are
applied for 24 h (activation phase), then are washed away,
and neurons are replated and grown for 18 h (growth
phase) in the absence of drug (Fig. 1A). This allows us to
identify drugs that mimic preconditioning and reprogram
neurons into a regenerative state rather than drugs that
act locally to regulate growth cone and cytoskeletal dy-
namics. We used this assay to screen 480 drugs for
their ability to induce axonal outgrowth.
Previously, we discovered that nocodazole, a drug that
disrupts microtubules, activates the pro-regenerative ki-
nase DLK and induces robust regeneration (Valakh et al.,
2015). Thus, we used nocodazole as a positive control
(Fig. 1A–D). Nocodazole controls were normalized to
DMSO controls from the same plate to control for plate-
to-plate variability. Nocodazole consistently induced ro-
bust growth on each plate, giving a mean value of 3.9-fold
over DMSO for the entire screen (Fig. 1D, n  24 plates,
df  46, p  0.0001). We identified several drugs that
would be expected to induce regeneration. These in-
cluded cytoskeletal disrupting agents such as podofilox,
mebendazole, febendazole, and nocodazole, as well as
the PKA stimulator, forskolin (data not shown). We also
identified capsaicin and arvanil, 2 TRPV1 agonists, that
induced a 2.5- and 2.1-fold increase in neurite outgrowth,
respectively (Fig. 1E, df  6, capsaicin p  0.01, arvanil
p 0.04). Because TRPV1 had not previously been linked
to promoting axonal regeneration, we explored this find-
ing further.
Our automated assay allowed us to screen hundreds of
drugs, but it has limitations. For example, the pipeline is
not able to determine which neurites belong to which
neuron. Instead, the neurite length analysis normalizes
total neurite length to the total number of neurons, leaving
us blind to the behavior of individual neurons. This is of
particular import, because TRPV1 is expressed in only a
subset of nociceptive neurons. To get a clearer picture of
how the population of neurons responded to these drugs,
we measured mean neurite length of individual neurons.
Capsaicin induced a 1.7-fold increase in mean neurite
length (Fig. 1F,G, df  4, p  0.04). While not all neurons
extended long neurites, capsaicin shifted the distribution
of neurons with neurites (Fig. 1H): fewer cells had short
neurites, 50 m (df  12, p  0.001) and more neurons
had longer neurites,150 m (df 12, p 0.001, Fig. 1I).
We conclude that capsaicin induces axon outgrowth in a
subset of neurons.
Acute capsaicin induces axon outgrowth in vitro
Capsaicin is an agonist for the nociceptive ion channel
TRPV1 (Caterina et al., 1997). TRPV1 opens transiently in
response to stimulation. Therefore, we tested whether
transient capsaicin exposure was sufficient to promote out-
growth. Neurons treated with capsaicin for only the first 10
min of the activation phase showed a 1.7-fold increase in
axon outgrowth compared to DMSO (Fig. 2A–C, df 4, p
0.007). This was similar to the increase we saw when cap-
saicin was applied for 24 h. The increased neurite length was
apparent as a shift in the distribution of neurons with long
neurites (Fig. 2D). Indeed, capsaicin induces a decrease in
neurons with short neurites and an increase in neurons
with long neurites (Fig. 2E, df  12, p  0.002, 1, 0.002
for each bin, respectively). These results are consistent
with a role of an ion channel such as TRPV1 in stimu-
lating a preconditioning-like response.
TRPV1 is required for capsaicin-induced outgrowth
Capsaicin is a well-known agonist for TRPV1. There-
fore, we hypothesized that TRPV1 mediates capsaicin-
induced axon outgrowth. We first tested this hypothesis
using the well-validated TRPV1 inhibitor capsazepine
(CPZ). CPZ was added 10 min before capsaicin and left
on through the 10-min capsaicin treatment. After capsa-
icin treatment, both drugs were washed out. Neurons
were replated 24 h later and grown for an additional 18 h.
CPZ blocked the 2.4-fold increase in outgrowth caused
by capsaicin (Fig. 3A,B, df  9, vehicle p-value  0.0005,
CPZ p-value  0.6, vehicle vs. CPZ capsaicin p-value 
0.008). Capsazepine also blocked the shift in distribution
of neurons with longer neurites (Fig. 3C, df  27, vehicle
p-value  0.0001, 1, 0.0001 and CPZ p-value  0.09, 1,
1 for each bin respectively). To further assess the require-
ment for TRPV1, we tested DRG neurons from TRPV1 KO
mice. Physiologic responses to capsaicin are completely
absent in these mice (Caterina et al., 2000). DRG neurons
from wild-type and TRPV1 KO mice were treated with
capsaicin for 10 min and replated (as in Fig. 2A). Genetic
loss of TRPV1 completely blocked capsaicin-induced out-
growth as assessed by mean neurite length (Fig. 3D, E,
df  9, WT p-value  0.006, KO p-value  1, WT vs. KO
p-value  0.009) as well as the population shift toward
having longer neurites (Fig. 3F, df  27, WT p-values 
0.0004, 1, 0.002, KO p-values  1, 1, 1, WT versus KO
p-values  0.0004, 1, 0.004 for each bin, respectively).
Importantly, TRPV1 KO DRG neurons grew normally in
culture following dissection from the animal and were
indistinguishable from wild-type neurons before drug
treatment (data not shown) indicating that they have the
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Figure 1. Drug screen identifies TRPV1 agonists as progrowth drugs. A drug screen was performed to identify drugs that could induce
a regenerative state. A, B, Experimental design. After 4–6 d in culture, neurons were treated for 24 h, then drugs were washed out
and neurons were replated. After 18 h of growth, neurons were fixed and stained to assess axon growth. 40 compounds were tested
per plate with 10 negative controls (DMSO) and 10 positive controls (NOC). Outer wells were filled with water to minimize evaporation.
C, Fluorescence images for Hoechst (nuclei) and III-tubulin (neuron specific marker) are shown. Note that the non-neuronal cell
(III-tubulin negative nucleus, yellow arrowhead) is not counted. Note the debris (yellow arrow) is not traced. Neurite tracings are
shown in red. D, Nocodazole induces robust growth in this high-throughput assay. Nocadazole-treated wells were normalized to
DMSO-treated wells from the same plate, therefore DMSO 1 (dashed line). Each data point represents one plate. Twenty-four plates
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ability to grow after injury. Therefore, the lack of out-
growth following capsaicin is not due to an inability of
TRPV1 KO DRG neurons to grow. This demonstrates that
axon outgrowth following capsaicin treatment is via
TRPV1 activation.
Capsaicin induces axon outgrowth in nociceptive
neurons
Having demonstrated that TRPV1 is required for
capsaicin-induced outgrowth, we next sought to deter-
mine if axon outgrowth was occurring in nociceptive neu-
rons. We used neurofilament 200 (NF200) immunostaining
to classify neurons as large-diameter, non-nociceptive
neurons (NF200; Frey et al., 2015). NF200-negative neu-
rons displayed a 2.9-fold increase in mean neurite length
(Fig. 4A,B, df  23, p  0.003). NF200-positive neurons
did not show a significant increase in neurite length (Fig.
4A,B, df  23, p  1 compared to DMSO, p  0.004
capsaicin NF200 vs. NF200–). Similarly, NF200– neurons
showed a significant increase in the percentage of cells
having longer neurites, while NF200 neurons showed no
change (Fig. 4C, df  45, NF200 p-values  1, 1, 1,
NF200– p-values 0.0001, 1, 0.0001, NF200 vs. NF200–
p-values  0.0001, 1, 0.0001 for each bin, respectively).
These findings suggest that capsaicin induces a cell-
autonomous pro-regenerative signal within nociceptors.
TRPV1-induced axon outgrowth is not due to toxicity
of poorly growing neurons
Nociceptive neurons do not regenerate as well as non-
nociceptive neurons, and some reports demonstrate that
they upregulate pro-death molecules in response to injury
(Kalous and Keast, 2010; Hu et al., 2016; Berta et al.,
2017). Furthermore, activation of TRPV1 can ablate
TRPV1-expressing neurons and axon terminals (Mishra
and Hoon, 2010; Wang et al., 2017). Therefore, we con-
sidered the possibility that capsaicin induces cell death
via TRPV1 and eliminates poorly growing neurons from
the population, thereby artificially skewing the distribution
of neurons toward better axonal growth. To address this
possibility, we assessed the health of DRG neurons after
capsaicin treatment. Neurons were treated as in Fig 2A,
but instead of replating neurons after 24 h, they were incu-
bated with ethidium homodimer, a cell death marker. Viabil-
ity was not affected by capsaicin treatment (DMSO 88.1%
and CAPS 89.6% viable n 3, df 4, p 0.8). To assess
general health, neurons were also loaded with TMRM, a
mitochondrial potential dye. Again, mitochondrial potential
was not affected by capsaicin treatment (DMSO  1 and
CAPS  1.01 normalized intensity, n  3, df  2, p  0.8).
We conclude that capsaicin is not negatively impacting the
health of DRG neurons. This indicates that enhanced out-
growth following capsaicin treatment is not due to loss of
poorly growing neurons.
continued
were used in the screen. E, In this screen, two TRPV1 agonists: capsaicin (CAPS) and arvanil (ARV) increased axon outgrowth
compared to DMSO, (n 3 independent experiments). Capsaicin was validated by analyzing axon growth from individual neurons (10
M, n  5 independent experiments). Representative images are shown (F). Capsaicin induced a 1.7-fold increase in mean neurite
length (G) and shifted the distribution of cells toward having longer neurites (H, I). A representative cumulative distribution is shown
in H.
Figure 2. Capsaicin pulse induces axon outgrowth. Since TRPV1 opens transiently in response to stimulation, neurons were treated
transiently with a 10-min pulse of capsaicin (A). After 10 min, capsaicin was removed. Neurons were replated 24 h later and grown
for 18 h. Representative images are shown (B). Capsaicin induced a 1.7-fold increase in mean neurite length (C) and a subset of
neurons extended longer neurites (D, E). A representative cumulative distribution is shown in D. n  5 independent experiments.
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Capsaicin activates a pro-regenerative–like program
The pro-regenerative program works by upregulating
pro-growth genes. SCG10 is an excellent regeneration
marker because it is upregulated after injury, is specific to
regenerating neurons, and is robustly elevated after injury
in vivo and in vitro (Mason et al., 2002; Grenningloh et al.,
2004; Shin et al., 2012b, 2014; Frey et al., 2015). We found
that capsaicin upregulates SCG10 protein levels 1.8-
fold (Fig. 5A,B, df  4, p  0.01), The distribution of
SCG10 intensity revealed that only a small subset of
Figure 3. TRPV1 is required for capsaicin-induced outgrowth. We used capsazepine, a capsaicin antagonist, and TRPV1 KO mice to
determine if capsaicin-induced outgrowth required TRPV1. Neurons were treated with capsazepine (CPZ, 10 M) for 10 min before
capsaicin. After 10 min of capsaicin treatment, both drugs were washed away. Neurons were replated after 24 h and grown for 18
h. Representative images are shown (A). Capsazepine blocked capsaicin-induced outgrowth (B) and the increased proportion of
neurons with longer neurites (C). n  4 independent experiments. WT and TRPV1 KO neurons were treated as in Fig. 2A. TRPV1 KO
completely blocked capsaicin-induced outgrowth in both measures, mean neurite length (D, E) and distribution (F). Data are from 4
independent experiments.
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Figure 4. Capsaicin induces axon outgrowth in NF200– nociceptive neurons. To determine if outgrowth was being induced in
non-nociceptive (NF200) or nociceptive (NF200–) neurons, we performed the same experiment described in Fig. 2A, then colabeled
cells for III-tubulin and NF200. Yellow arrows indicate NF200– neurons (A). NF200– neurons (yellow arrow) showed increased mean
neurite length (B) with a significant shift in the percentage of cells extending long neurites (C). No change was observed in NF200
neurons treated with capsaicin. Mean neurite length was normalized to the entire population (NF200 and NF200–) of DMSO-treated
neurons. n  4 independent experiments.
Figure 5. Capsaicin upregulates the regeneration marker SCG10. To determine if the pro-regeneration program had been activated,
we assessed upregulation of the regeneration marker SCG10. Neurons were treated with capsaicin for 10 min. 24 h later, neurons
were fixed and stained for SCG10. Representative images (A) show an increase in mean SCG10 intensity (B) as well as an increase
in the percentage of neurons that have robust levels (1.75) of SCG10 in the cell body (C). n  5 independent experiments.
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neurons upregulated SCG10 (Fig. 5C). There is a de-
crease in the percentage of neurons with low-level ex-
pression (1.25, df  12, p  0.005) and a subsequent
increase in the percentage of neurons with robust SCG10
expression (1.75, df  12, p  0.007). This is consistent
with TRPV1 being activated in a subset of sensory neurons.
Together, the induction of SCG10 and the promotion of axon
outgrowth provides both molecular and functional evidence
that capsaicin “reprograms” cultured dorsal root ganglion
neurons into a regenerative-like state.
Extracellular calcium is required for capsaicin-
induced outgrowth
Having demonstrated that capsaicin promotes axon out-
growth, we next sought to define the mechanism by which
TRPV1 activation leads to the induction of the pro-growth
program. TRPV1 is permeable to bothNa andCa2, and thus
its activation depolarizes neurons thereby leading to an in-
crease in intracellular calcium. Calcium is a known mediator of
neuronal injury responses; injury triggers a calcium influx that is
involved in membrane resealing, growth cone formation, and
activation of the regenerative program (Bradke et al., 2012;Cho
et al., 2013; Rishal and Fainzilber, 2014). It is unknownwhether
calcium influx via ligand-gated ion channel activation could
mediate a regenerative response. Therefore, we tested
whether extracellular calcium was required in this paradigm.
Neurons were pretreated with EGTA for 10 min before cap-
saicin treatment. After capsaicin treatment, both drugs were
washed out, and neuronswere replated 24 h later and grown
for 18 h (Fig. 6A). Chelating extracellular calcium with EGTA
completely blocked both the increase in mean neurite length
(Fig. 6B,C, df 6, vehicle p-value 0.004, EGTA p-value 1,
vehicle vs. EGTAp-value 0.007) and the shift in population of
more neurons having longer neurites (Fig. 6D, df 18, vehicle
p-values 0.0001, 1, 0.0001, EGTA p-values 1, 1, 1, vehicle
vs. EGTA p-values  0.002, 0.7, 0.0001 for each bin, respec-
tively). These results indicate that there is a calcium-sensitive
pathway downstream of TRPV1 activation that induces the
pro-regenerative program. Importantly, EGTA did not affect
baseline growth. This shows that EGTA is not blocking out-
growth via nonspecific damage to neurons.
Capsaicin activates the PKA pathway to induce axon
outgrowth
The cAMP/PKA pathway is stimulated by calcium influx
and is well recognized for its ability to activate axon
Figure 6. Extracellular calcium is required for capsaicin-induced outgrowth. To determine if Ca2 influx was required for outgrowth
induced by capsaicin, neurons were treated with EGTA to chelate extracellular calcium for 10 min before capsaicin addition. After the
10-min capsaicin pulse, both drugs were removed, and neurons were cultured for 24 h before replating (A). Representative images
(B) illustrate that EGTA robustly blocked capsaicin-induced outgrowth. EGTA blocked the increase in mean neurite length (C) and the
increased number of neurons with longer neurites (D). n  3 independent experiments.
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regeneration (Cai et al., 1999; Neumann et al., 2002;
Cooper, 2015). To test whether capsaicin activates the
PKA pathway, we assessed phosphorylation of the down-
stream, pro-regenerative transcription factor CREB. Neu-
rons were pretreated with DMSO or the PKA inhibitor, H89,
for 30 min, followed by capsaicin for 10 min. Inhibitors were
present during the 10-min capsaicin treatment and for 20
min after capsaicin was removed (Fig. 7A). Then neurons
were fixed and stained for phosphorylated CREB. Capsaicin
induced a 2-fold increase in pCREB that was attenuated
by PKA inhibition (Fig. 7B,C, df  12, vehicle p-value 
0.003, PKAi p-value  0.1). As with SCG10, pCREB was
upregulated in only a subset of neurons (Fig. 7D, df  27,
vehicle p-values  0.0001, 1, 0.0003, PKAi p-values  0.1,
1, 1 for each bin, respectively).
Next, we tested the functional consequence of the PKA
pathway in capsaicin-induced outgrowth. Neurons were
pretreated with either DMSO or H89 for 30 min before the
10-min pulse of capsaicin. After capsaicin was removed,
DMSOor H89was added back (Fig. 8A). 24 h after capsaicin
treatment, DMSO and H89 were removed, and neurons
were replated and grown for 18 h in the absence of any drug.
PKA reduced the 2.4-fold increase in outgrowth (Fig. 8B,C,
df  6, vehicle p-value  0.0004, PKAi p-value  0.5,
vehicle vs. PKAi p-value 0.009) and the shift in distribution
of neurite lengths (Fig. 8D, df 18, vehicle p-values 0.002,
1, 0.0006, PKAi p-values  0.09, 1, 0.1, vehicle vs. PKAi
p-values  0.2, 1, 0.02 for each bin, respectively). This
indicates a role for the PKA pathway in capsaicin-induced
axon growth. We propose that capsaicin activates TRPV1 to
increase intracellular calcium, stimulating the PKA pathway
to induce phosphorylation of CREB and initiation of the
pro-regenerative program.
Capsaicin induces regeneration signaling in vivo
Having defined the mechanism by which capsaicin in-
duces axon outgrowth in vitro, we set out to determine if
axon growth could be enhanced by activating the pro-
regenerative program in vivo. Neurons preconditioned in
vivo will exhibit robust growth in a short amount of time,
Figure 7. Capsaicin induces PKA-dependent pCREB. To identify the signaling pathway involved in capsaicin-induced outgrowth, we
assessed phosphorylation of the pro-regenerative transcription factor CREB. A, Vehicle or H-89 (PKAi, 5 M) was applied 30 min before
DMSO/capsaicin treatment. After 10 min, drugs were washed out, and vehicle/PKAi were reapplied. 20 min later neurons were fixed and
stained (B–D). Overall, there was an 2-fold increase in pCREB intensity (C, n  4 independent experiments). D, The distribution showed
that only a subset of neurons had robust pCREB upregulation. Capsaicin-induced pCREB was decreased by PKA inhibition.
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for example 18 h, whereas uninjured neurons will not (Shin
et al., 2012a). Indeed, we find that neurons that have been
pre-injured display 200  13 m of growth in 18 h com-
pared to only 32  16 m from uninjured neurons, a
6.3-fold increase (Fig. 9A–C, n  3 per condition, df  5,
p-value 0.0005). This robust increase in axon outgrowth
is also observed as a decrease in the percentage of
neurons with short axons and a subsequent increase in
the percentage of neurons with long axons (Fig. 9D, df 
12, p-value  0.0001, 1, 0.0001 for each bin, respec-
tively). A common paradigm to determine if drugs induce
a similar preconditioning-like response in vivo is to apply
drug to the sciatic nerve then isolate DRGs a few days
later and assess axon regeneration in vitro (Neumann
et al., 2002; Valakh et al., 2015). We used this method to
ask two questions: (1) does capsaicin induce a precondi-
tioning like response in vivo? and (2) does capsaicin act
locally on axons to induce regeneration? Since TRPV1 is
expressed in the sciatic nerve, we applied 200 M cap-
saicin directly to the sciatic nerve (Gold et al., 2003; Xing
et al., 2012). 2 d later, DRGs were collected and cultured
for 18 h to determine if treatment mimicked precondition-
ing (Fig. 9A). In vivo local capsaicin improved mean neu-
rite outgrowth 1.5-fold over vehicle (Fig. 9E,F, df  12,
p-value  0.004) and shifted a subset of neurons toward
having longer neurites (Fig. 9G, df 36, p-values 0.008,
1, 0.02 for each bin, respectively). Capsaicin-induced
axon outgrowth is not as robust as injury-induced out-
growth. This is expected, since capsaicin is inducing
outgrowth in only a small subset of neurons, whereas
injury will induce regeneration in most neurons. This find-
ing confirms that the pro-regenerative pathway can be ac-
tivated by capsaicin in vivo. We further tested whether
capsaicin was sufficient to promote axon regeneration in
vivo. We repeated the previous experiment but crushed the
nerve instead of culturing the DRG 2 d after drug treatment.
24 h after crush, nerves were collected and analyzed.We did
not observe improved regeneration in this paradigm (Fig.
9H). The measured regeneration index was 300  71 and
390 68 m for DMSO and Capsaicin, respectively (df 6,
p  0.4). These values are similar to what is observed from
nerves that are not preconditioned (Shin et al., 2012a). This
suggest that either capsaicin is not sufficient to activate
enhanced regeneration in this fully in vivo paradigm or that
Figure 8. Capsaicin-induced axon growth is PKA-dependent. To determine if PKA was required for axon growth, we pretreated
neurons with PKAi for 30 min before capsaicin treatment. PKAi remained on the cells during capsaicin treatment and during the rest
of the activation phase (A). PKAi diminished the increase observed in mean neurite length (B,C) and the increase in the proportion of
neurons with long neurites (D). n  3 independent experiments.
Confirmation 11 of 15
May/June 2018, 5(3) e0095-18.2018 eNeuro.org
this assay is not sensitive to changes in axonal growth in a
small subpopulation of neurons.
Discussion
After injury, long-distance regeneration requires a com-
plex and coordinated pro-regenerative transcriptional
program. However, this program has limitations. It is often
too slow, and distal targets degenerate before reinnerva-
tion is achieved (Gordon et al., 2011). Furthermore, some
cell types respond poorly or not at all. The preconditioning
phenomenon illustrates that the pro-regenerative program
can be augmented to improve regeneration. Activation of
the program in DRG neurons by injury accelerates regen-
eration of the peripheral axon and allows for regenera-
tion of the normally regeneration-resistant central axon
Figure 9. Capsaicin applied to the sciatic nerve induces axonal outgrowth. Progrowth signaling can be activated in vivo and observed in
vitro (A). Preconditioning nerve crush induces robust axon outgrowth (B–D, n 3). To determine if this capsaicin pathway is active in vivo,
capsaicin was applied locally to the mouse sciatic nerve. After 2 d, L4/5 DRG were removed and cultured for 18 h to determine if local
capsaicin had induced a pro-regenerative program. Representative images (E) show that capsaicin treatment induced axon outgrowth and
increased mean neurite length (G) and shifted a subset of neurons toward longer growth (G). n  7 independent experiments. H,
Representative images of sciatic nerve show that capsaicin was insufficient to induce regeneration in the sciatic nerve.
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(McQuarrie and Grafstein, 1973; McQuarrie et al., 1977;
Richardson and Issa, 1984). We wished to identify phar-
macological agents that mimic the preconditioning pro-
gram in the absence of injury in hopes of promoting
regeneration in regeneration-resistant neurons. We cul-
tured neurons for several days to allow the initial injury
signaling cascade, which is activated by dissection of the
neurons from the animal, to turn off (Frey et al., 2015). This
allowed us to test a drug’s ability to induce a regeneration
response in the absence of ongoing injury signaling. This
was an important element of our assay, because injury
activates all pro-growth pathways and induces extremely
robust regeneration. By replating neurons to assess ax-
onal growth, we were also able to separate the “activa-
tion” phase from the “growth” phase and expose neurons
to drugs only in the activation phase. This allowed us to
select for drugs that induce a pro-regenerative program
as opposed to drugs that might facilitate growth cone
formation or cytoskeletal assembly. In this process, we
discovered a method to stimulate known pro-regenerative
pathways with a nociceptive ligand. Excitingly, nocicep-
tive neurons are known to be poor at axon regeneration
(Leclere et al., 2007; Kalous and Keast, 2010). The con-
cept of targeting specific neuronal populations for regen-
eration via ligand activation may be generalizable.
Previous studies discovered that electrically stimulating
neurons upregulated regeneration-associated genes and
improved neurite outgrowth during stimulation (Goldberg
et al., 2002). More recently, this technique has been
tested in vivo and shown to mimic the preconditioning
response (Senger et al., 2018). We discovered that the
TRPV1 agonist, capsaicin, mimicked the preconditioning
paradigm and induced axon outgrowth. This is unlike
previous studies, since we can transiently stimulate a
single receptor to mimic preconditioning. Stimulation of
TRPV1 induces calcium influx and subsequent activation
of PKA and the pro-regenerative transcription factor
CREB. Furthermore, we show that local application of
capsaicin to the sciatic nerve is sufficient to mimic a
conditioning lesion. This indicates that activation of
TRPV1 along the nerve can stimulate this pathway in vivo.
Interestingly, we found that not all methods of calcium
stimulation induced axonal outgrowth. Indeed, ionomycin
fails to induce regenerative signaling or enhance neurite
outgrowth (data not shown and Valakh et al., 2015). This
suggests that TRPV1 may stimulate a signaling complex
that is activated by local calcium influx. Scaffolding pro-
teins can organize large complexes of signaling proteins
with ion channels. In this case, the adaptor protein
AKAP150 is an interesting candidate, as it can anchor
PKA and adenylate cyclase and interacts with ion chan-
nels (Dell’Acqua et al., 2006; Efendiev et al., 2010).
AKAP150 is expressed in 80% of TRPV1-positive neurons
and physically interacts with TRPV1 (Schnizler et al.,
2008; Efendiev et al., 2013). Therefore, it is possible that a
TRPV1/AC/PKA/AKAP150 complex exists, and calcium
influx from TRPV1 activation could locally activate this
signaling module. We hypothesize that TRPV1 activation
triggers a local influx of calcium, either directly or indi-
rectly, to stimulate adenylate cyclase. Local cAMP pro-
duction then activates PKA to turn on a pro-regenerative
program via pCREB-dependent transcription.
The desire to regenerate non-nociceptive neurons is
obvious. In the absence of these neurons, patients lose
the ability to control their body and interact with their
environment. The need to regenerate nociceptive neurons
is less obvious but could be beneficial for multiple rea-
sons. First, appropriate pain has its place. After injury,
pain elicits guarding behaviors so that the injury is pro-
tected and given time to heal. In cases where individuals
are unable to sense pain, such as diabetic neuropathy,
they must monitor themselves for injury. Second, nocice-
ptive neurons play an important role in neuroinflammation
and vasodilation after tissue injury that facilitates wound
healing (Barker et al., 2006; Chiu et al., 2012). Therefore,
restoring function of nociceptors after injury could facili-
tate wound healing and prevent additional injuries.
Compared to large myelinated neurons, nociceptive
neurons do not regenerate well (Leclere et al., 2007;
Kalous and Keast, 2010), likely because of higher expres-
sion of growth inhibitory molecules as well as an inability
to upregulate growth-promoting molecules (Gardiner
et al., 2005; Christie et al., 2010). This study suggests that
it may be possible to target regeneration-resistant neu-
rons that express TRPV1 to overcome their inability to
regenerate. Moreover, a deeper understanding of this
pathway may identify methods to promote axonal re-
growth from other regeneration-resistant neurons. The
CNS does not regenerate after injury, yet it is susceptible
to many types of axon injury (trauma, multiple sclerosis,
white matter strokes). Interestingly, TRPV1 is expressed in
some brain regions (Cavanaugh et al., 2011). If the com-
ponents of this regeneration pathway are intact within the
CNS, then this pathway may be useful for promoting
regeneration in regeneration-resistant CNS neurons.
Prior studies have demonstrated that ion channel inhi-
bition can promote axon regeneration (Tedeschi et al.,
2016). Our work highlights the potential of extracellular ion
channel ligands to activate known pro-regenerative path-
ways. Indeed, other ligands may induce complementary
regeneration pathways and/or stimulate regeneration of
additional neuronal cell types. In theory, with the proper
complement of agonists, it may be possible to achieve
targeted regeneration of damaged neurons while leaving
unaffected neurons undisturbed.
Conclusion
We provide evidence that stimulating TRPV1 mimics
preconditioning and induces a pro-regenerative pro-
gram mediated by calcium influx and PKA activation.
PKA subsequently leads to phosphorylation of the pro-
growth transcription factor CREB and upregulation of
regeneration-associated proteins such as SCG10. This is
the first example of an ion channel agonist inducing a sig-
naling cascade to initiate regeneration. Ion channels are
attractive therapeutic targets and could promote cell type–
specific regeneration.
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